Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 169

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 169
---
Period”), (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to
sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of
capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company;
(ii) file or caused to be filed any registration statement with the Commission relating to the offering of any shares of capital stock
of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (iii) complete
any offering of debt securities of the Company, other than entering into a line of credit with a traditional bank, or (iv) enter into
any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of capital
stock of the Company, whether any such transaction described in clause (i), (ii), (iii) or (iv) above is to be settled by delivery of
shares of capital stock of the Company or such other securities, in cash or otherwise. Additionally, the Company’s directors and
officers and any other holder(s) of 10% or more of the issued and outstanding ordinary shares the outstanding shares of Common Stock
as of the effective date of the Registration Statement (and all holders of securities exercisable for or convertible into shares of Common
Stock) shall enter into customary “lock-up” agreements in favor of D. Boral pursuant to which such persons and entities shall
agree, for a period of sixty (60) days after the Closing of Offering, that they shall not offer, pledge, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or
otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities convertible into
or exercisable or exchangeable for shares of capital stock of the Company, subject to customary exceptions. The foregoing restrictions
shall also be contained and set forth in the Underwriting Agreement and customary “lock-up” agreements, as applicable.

Tail Financing

Subject to FINRA Rule 5110(g)(5)(B), the Representative is entitled to a cash fee equal to 7.0% of the aggregate gross proceeds received
by the Company from the sale of any equity